# Qisuanfa

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/qisuanfa

- Industry: Software
- Headquarters: Chongqing, China
- Website: www.qialg.com.cn/
- Latest round: Series A (Nov 14, 2025)
- Investors on record: 2

## About

Based in Chongqing, China and founded in 2022, Chongqing Qisuanfa Technology Co., Ltd., trading as Qisuanfa, provides AI-driven healthcare technology solutions for the pet healthcare and artificial intelligence industry. Its founder Chen Li graduated from King's College London and is a researcher at Qlalgorithm Lab, as well as a serial entrepreneur. In May 2026, it closed a venture funding from QF Capital and Juheng Chuangxiang.
Qisuanfa develops pet healthcare technology solutions centered on large-model AI systems, combining cloud-based models and edge computing deployment, with offerings including AI-assisted diagnostic platforms for veterinarians, pet health management systems, and smart hardware products such as wearable devices and feeding equipment, while also providing data-driven services covering diagnosis support, health monitoring, behavioral analysis, and treatment pathway recommendations, forming an integrated ecosystem that connects AI models, clinical data, pet hospitals, and consumer-facing applications.
The company generates revenue primarily through AI software platforms, smart hardware sales, and related pet healthcare services, including diagnostic support systems, data services, and connected device products.
The company will use the funding in May 2026 for product iteration, model capability deepening, and market expansion. It also plans to further develop a question-and-answer search and recommendation engine for the pet industry, aiming to become an infrastructure platform in the pet health management field, providing personalized health management and services for every pet.

## Funding rounds

- Series A, Nov 14, 2025 — QF Capital, Juheng Chuangxiang

## Investors

- QF Capital (https://capitalatlas.ai/funds/qf-capital) — Series A
- Juheng Chuangxiang — Series A